Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V (open House Model) - Drug 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a (8)/130c (1) Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (n05ax13) And The Trade Name Trevicta® Within The Framework Of A So-called Open-house Model. 2026-10-01
Norway Bekkeløp Sundre - Entreprise 1 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Vildagliptin (a10bh02) Within The Framework Of A So-called Open-house Model. 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a (8)/130c (1) Sgb V For Medicinal Products Containing The Active Ingredient Iron(iii) Sodium Gluconate Complex (b03ac07) Within The Framework Of A So-called Open-house Model. 2026-10-01
Germany Pharmaceutical Discount Agreements From 01.12.2024 For Various Active Ingredients Within The Framework Of An Open-house Procedure 2026-10-01
Portugal Delivery And Removal Service Of Containers Of 7.5 M3 Capacity For Transporting Waste From Rcds To Managers 2026-10-02
Finland Veikkaus Oy Research Services 2026-10-03
Germany Dynamic Purchasing System For Offsetting The Ecb’s Greenhouse Gas Emissions 2026-10-03
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Erythropoietin (exclusively Epoetin Zeta), (obo), Atc B03xa01 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Whats app